Palvella Therapeutics (PVLA) Shares Outstanding (2013 - 2026)

Palvella Therapeutics (PVLA) has 14 years of Shares Outstanding data on file, last reported at $14.3 million in Q1 2026.

• Quarterly Shares Outstanding rose 29.87% year-over-year to $14.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.3 million (up 29.87% YoY) and the FY2025 annual result came in at $12.4 million, up 12.43% from the prior year.
• Shares Outstanding rose to $14.3 million in Q1 2026 per PVLA's latest filing, from $12.4 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $74.3 million in Q2 2022 and bottomed at $15617.0 in Q2 2025.
• The 5-year median for Shares Outstanding is $1.8 million (2022), against an average of $8.6 million.
• The widest annual swing landed in 2022, when Shares Outstanding soared 529171.43%; it then slumped 99.98% in 2023.
• Tracing PVLA's Shares Outstanding over 5 years: stood at $1.8 million in 2022, then changed by 0.0% to $1.8 million in 2023, then surged by 522.09% to $11.0 million in 2024, then grew by 12.43% to $12.4 million in 2025, then gained by 15.61% to $14.3 million in 2026.
• Per Business Quant, the three latest PVLA Shares Outstanding figures stand at $14.3 million (Q1 2026), $12.4 million (Q4 2025), and $11.1 million (Q3 2025).

Peer Comparison